Skip to main content
Fig. 1 | AIDS Research and Therapy

Fig. 1

From: HIV-1 acquired drug resistance to integrase inhibitors in a cohort of antiretroviral therapy multi-experienced Mexican patients failing to raltegravir: a cross-sectional study

Fig. 1

Proportion of samples with genotype-predicted resistance to integrase strand-transfer inhibitors. Absolute numbers are shown above each bar. RAL raltegravir, EVG elvitegravir, DTG dolutegravir, BIC bictegravir, S Susceptible (score 0–9), PLLR Potential low-level resistance (score 10–14), LLR Low-level resistance (score 15–29), IR Intermediate resistance (score 30–59), HLR High-level resistance (score ≥ 60); N = 25

Back to article page